The National Exposure Registry: Analyses of Health Outcomes From the Benzene Subregistry

Toxicology and Industrial Health

Volumn 14, Issue 3, 1998, Pages 367-387

  Burg, Jeanne R ^a   Gist, Ginger L ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Agency for Toxic Substances and Disease Registry; ATSDR; Baseline; BL; CER; CI; Comprehensive Environmental Response; confidence interval; F1; F2; Followup 1; Followup 2; NCHS; National Center for Health Statistics; National Exposure Registry; National Health Interview Survey; National Household Survey on Drug Abuse; National Priority List; NER; NHIS; NHSDA; NPL; O E; observed expected; parts per billion; ppb; SIR; SMR; standardized incidence ratio; standardized mortality ratio; TCR; Texas Cancer Registry

Indexed keywords

BENZENE; DRINKING WATER;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; BRONCHITIS; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH HAZARD; HEALTH STATUS; HEARING DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SPEECH DISORDER; WATER CONTAMINATION;

ADOLESCENT; ADULT; AGED; BENZENE; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; FEMALE; FEMALE UROGENITAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; REGISTRIES; RESPIRATORY HYPERSENSITIVITY; SKIN DISEASES; TEXAS; UNITED STATES; WATER POLLUTANTS, CHEMICAL;

EID: 0031924660     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/074823379801400301     Document Type: Article

References (85)

1. Agency For Toxic Substances And Disease Registry (Atsdr) (1988a). Policies and Procedures for Establishing a National Registry of Persons Exposed to Hazardous Substances: National Exposure Registry. PB95-154571. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
2. Agency For Toxic Substances And Disease Registry (Atsdr) (1988b). Hazardous Substances Priority List, Toxicological Profiles, Second List. Federal Register 53:41280.
3. Agency For Toxic Substances And Disease Registry (Atsdr) (1988c). VIEW Database. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
4. Agency For Toxic Substances And Disease Registry (Atsdr) (1989). Toxicological Profile for Benzene. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA. Report no.: ATSDR/TP-88/03.
5. Agency For Toxic Substances And Disease Registry (Atsdr) (1992). HazDat Version 1.5. User's Manual. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
6. Agency For Toxic Substances And Disease Registry (Atsdr). (1993). Toxicological Profile for Benzene (Update). U.S. Department of Health and Human Services, Public Health Service. Atlanta, GA.
7. Agency For Toxic Substances And Disease Registry (Atsdr) (1994). National Exposure Registry—Policies and Procedures Manual for Establishing a National Registry of Persons Exposed to Hazardous Substances: National Exposure Registry. PB95-154571. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
8. Agency For Toxic Substances And Disease Registry (Atsdr) (1995). National Exposure Registry Benzene Subregistry Baseline Technical Report. NTIS Publication No. PB95-255766. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
9. Aoyama, K. (1986). “Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice.” Toxicol. Appl. Pharmacol. 85:92-101.
10. Austin, H., Delzell, E., and Cole, P. (1988). “Benzene and leukemia: a review of the literature and a risk assessment.” Am. J. Epidemiol. 127:419-439.
11. Avis, S.P. and Hutton, C.J. (1993). “Acute benzene poisoning: a report of three fatalities. “ J. Forensic Sci. 38:599-602.
12. Baker, R.J. and Nelder, J.A. (1978). Generalized Linear Interactive Modeling. Release 3.77. Royal Statistical Society, Oxford, UK.
13. Breslow, N.E. and Day, N.E. (1987). Statistical Methods in Cancer Research, Vol. 2. The Design and Analysis of Cohort Studies. International Agency for Research on Cancer, Lyon, France.
14. Brief, R.S., Lynch, J., Bernath, T., and Scala, R.A. (1980). “Benzene in the workplace.” Am. Ind. Hyg. Assoc. J. 41:616-623.
15. Burg, J.R., Allred, S.L., and Sapp, J.H. II (1997). “The potential for bias due to attrition in the National Exposure Registry: an examination of reasons for nonresponse, nonrespondent characteristics and the response rate.” Toxicol. Ind. Health. 13:1-13.
16. Burg, J.R. and Gist, G.L. (1995). “The National Exposure Registry: procedures for establishing a registry of persons environmentally exposed to hazardous substances. “ Toxicol. Ind. Health 11:231-248.
17. Ciranni, R., Barale, R., and Adler, I-D. (1991). “Dose-related clastogenic effects induced by benzene in bone marrow cells and in differentiating spermatogonia of Swiss CD1 mice. “ Mutagen. 6:417-421.
18. Comprehensive Environmental Response, Compensation, And Liability Act (Cercla) (1980). Public Law (PL) 95-510, codified together with SARA at 42 USC 9601 et seq.
19. Cox, L.A. (1991). “Biological basis of chemical carcinogenesis: insights from benzene.” Risk Anal. 11:453-464.
20. Csata, S., Gallyas, F., Frang, D., and Toth, M. (1971). “Nephrotoxic anuria.” Intl. Urology Nephrology 3(2):181-201.
21. Dagg, T.G., Satin, K.P., Bailey, W.J., Wong, O., Harmon, L.L., and Swencicki, R.E. (1992). “An updated cause specific mortality study of petroleum refinery workers.” Br. J. Ind. Med. 49:203-212.
22. Davies, J.E. and Levine, R.S. (1986). “Human health effects of benzene.” In: Benzene in Florida Groundwater: An Assessment of the Significance to Human Health. Florida Petroleum Council, Tallahassee, FL. pp. 16–35.
23. Eastmond, D.A. (1993). “Induction of micronuclei and aneuploidy by the quinone-forming agents benzene and o-phenylphenol.” Toxicol. Lett. 67(1-3):105-118.
24. Enterline, P.E. and Viren, J. (1985). “Epidemiologic evidence for an association between gasoline and kidney cancer.” Environ. Health Perspect. 62:303-312.
25. Fielder, R.J., Sorrie, G.S., Bishop, C.M., Gompertz, D., Fletcher, A.P., and Van Den Heuvel, M.J. (1982). “Benzene. Toxicity review 4.” Health and Safety Executive. pp. 1–36.
26. Fisher, A.A. (1975). Contact Dermatitis. Lea and Febiger, Philadelphia, PA.
27. Gist, G.L. and Burg, J.R. (1995). “Methodology for selecting substances for the National Exposure Registry.” J. Expos. Anal. Environ. Epidemiol. 5:197-208.
28. Gist, G.L., Burg, J.R., and Radtke, T.M. (1994). “The site selection process for the National Exposure Registry.” J. Environ. Health 56(6):7-12.
29. Greenburg, L. (1926). “Benzene poisoning as an industrial hazard. VII. Results of medical examination and clinical tests made to discover early signs of benzol poisoning in exposed workers.” Public Health Reports 41:1526-1539.
30. Hansson, L.E., Nyren, O., Hsing, A.W., Bergstrom, R., Josefsson, S., Chow, W.H., Fraumeni, J.F., JR., et al. (1996). “The risk of stomach cancer in patients with gastric or duodenal ulcer disease.” N. Engl. J. Med. 335(4):242-249.
31. Harrington, J.M. (1987). “The health experience of workers in the petroleum manufacturing and distribution industry—a review of the literature.” Am. J. Ind. Med. 12:475-497.
32. Harrington, J.M., Whitby, H., Gray, C.N., REID, F.J., AW, T.C., and WATERHOUSE, J.A. (1989). “Renal disease and occupational exposure to organic solvents: a case referent approach. “ Br. J. Ind. Med. 46:643-650.
33. Harris, M.I. and Zimmet, P. (1992). “Classification of diabetes mellitus and other categories of glucose intolerance.” In: International Textbook of Diabetes Mellitus (K.G. Alberti, R.A. DeFronzo, H. Keen, P. Zimmet, eds.). Wiley and Sons, Chichester, UK. pp. 3–18.
34. Henderson, R.F., Sabourin, P.J., Bechtold, W.E., Griffith, W.C., Medinsky, M.A., Birnbaum, L.S., and Lucier, G.W. (1989). “The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites.” Environ. Health Perspect. 82:9-17.
35. Hsieh, G.C., Sharma, R.P., and Parker R.D.R. (1988). “Subclinical effects of groundwater contaminants. I. Alteration of humoral and cellular immunity by benzene in CD-1 mice.” Arch. Environ. Contam. Toxicol. 17:151-158.
36. Hsieh, G.C., Parker, R.D.R., Sharma, R.P., and Hughes, B.J. (1990). “Subclinical effects of groundwater contaminants. III. Effects of repeated oral exposure to combinations of benzene and toluene on immunologic responses in mice.” Arch. Toxicol. 64:320-328.
37. International Agency For Research On Cancer (Iarc) and International Association Of Cancer Registries (1982a). “ Benzene.” In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Industrial Chemicals and Dyestuffs. IARC, Lyon, France. 29:93-148.
38. International Agency For Research On Cancer (Iarc) and International Association Of Cancer Registries (1982b). “ The rubber industry.” In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Industrial Chemicals and Dyestuffs. IARC, Lyon, France. 28:183-225.
39. International Agency For Research On Cancer (Iarc) (1987). “On the evaluation of carcinogenic risk of chemicals to humans: Overall evaluations of carcinogenicity: an updating of IARC monographs 1 to 42.” IARC, Lyon, France. Suppl. 7:120-122.
40. Juntunen, J. (1982). “Alcoholism in occupational neurology: diagnostic difficulties with special reference to the neurological syndromes caused by exposure to organic solvents.” Acta Neurol. Scand. (Suppl) 66:89-108.
41. King, A.G., Landreth, K.S., and Wierda, D. (1987). “Hydroquinone inhibits bone marrow pre-B cell maturation in vitro.” Mol. Pharmacol. 32(6):807-812.
42. Kipen, H.M., Cody, R.P., and Goldstein, B.D. (1989). “Use of longitudinal analysis of peripheral blood counts to validate historical reconstructions of benzene exposure.” Environ. Health Perspect. 82:199-206.
43. Klavis, G. and Drommer, W. (1976). “Goodpasture syndrome and the effects of benzene. “ Arch. Toxicol. 26(1):40-55.
44. Lange, A., Smolik, W., Zatonski, W., and Szymanska, J. (1973). “Serum immunoglobulin levels in workers exposed to benzene, toluene, and xylene.” Int. Arch. Arbeitsmed. 31:37-44.
45. Leong, B.K.J. (1977). “Experimental benzene intoxication.” J. Toxicol. Environ. Health Suppl. 2:45-61.
46. Lerang, F., Moum, B., Haug, J.B., Tolas, P., Breder, O., Aubert, E., Hoie, O., et al. (1997). “Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?” Am. J. Gastroenterol. 92(2):248-253.
47. Lewis, J.G., Odom, B., and Adams, D.O. (1988). “Toxic effects of benzene and benzene metabolites on mononuclear macrophages.” Toxicol. Appl. Pharmacol. 92:246-254.
48. Li G-L., Yin, S-N., Watanabe, T., Nakasuka, H., Kasahara, M., Abe, H., and Ikeda, M. (1986.) “Benzene-specific increase in leukocyte alkaline phosphatase activity in rats exposed to vapors of various organic solvents. “ J. Toxicol. Environ. Health 19:581-589.
49. Lloyd, J.W., Decoufle, P., and Salvin, L.G. (1977). “Unusual mortality experience of printing pressmen. “ J. Occup. Med. 19:543-550.
50. McGuigan, J.E. (1996). “Helicobacter pylori: The versatile pathogen.” Dig. Dis. 14(5):289-303.
51. McMurry, S.T., Lochmiller, R.L., Vestey, M.R., Qualls, C.W., and Elangbam, C.S. (1991). “Acute effects of benzene and cyclophosphamide exposure on cellular and humoral immunity of cotton rats, Sigmodon hispidus. “ Bull. Environ. Contam. Toxicol. 46:937-945.
52. Medinsky, M.A., Schlosser, P.M., and Bond, J.A. (1994). “Critical issues in benzene toxicity and metabolism: The effect of interactions with other organic chemicals on risk assessment. “ Environ. Health Perspect. 102 Suppl 9:119-124.
53. Meyne, J. and Legator, M.S. (1980). “Sex related differences in cytogenetic effects of benzene in the bone marrow of Swiss mice.” Environ. Mutagen. 2:43-50.
54. Midzenski, M.A., McDiarmid, M.A., Rothman, N., and Kolodner, K. (1992). “Acute high exposure to benzene in shipyard workers. “ Am. J. Ind. Med. 22:553-565.
55. National Cancer Institute (1989). Surveillance, Epidemiology and End Results Program (SEER) Data. National Cancer Institute, Bethesda, MD.
56. National Center For Health Statistics (Nchs) (1992). Compressed Mortality Files, U.S. 1979-1002 (Public Data Set). Center For Disease Control an Prevention, Office and Analysis and Epidemiology, Atlanta, GA.
57. National Center For Health Statistics (1990). Current Estimates from the National Health Interview Survey, United States, 1989. Vital and Health Statistics; Series 10, no. 164. Publication No. (PHS)90-1504. U.S. Department of Health and Human Services, Public Health Service, Washington, DC.
58. National Diabetes Data Group (1985). Diabetes in America. Diabetes Data Compiled in 1984. U.S. Department of Health and Human Services, Public Health Service, Washington, DC.
59. National Institute For Occupational Safety And Health (Niosh) (1988). Occupational Safety and Health Guideline for Benzene: Potential Human Carcinogen. Pub. No. 89-104, Suppl. II. U.S. Department of Health and Human Services, Public Health Service, Cincinnati, OH.
60. National Toxicology Program (Ntp) (1986). Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F Mice (Gavage Studies). NIH Pub. No. 86-2545. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
61. Niculescu, R., Bradford, H.N., Colman, R.W., and Kalf, G.F. (1995). “Inhibition of the conversion of pre-interleukins-1-alpha and 1-beta to mature cytokines by p-benzoquinone, a metabolite of benzene. “ Chemico-Biol. Interact. 98(3):211-222.
62. Ning, H., Kado, N.Y., Kuzmicky, P.A., and Hsieh, D.P. (1991). “Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells.” Environ. Mol. Mutagen. 18(1):1-5.
63. Post, G.B., Snyder, R., and Kalf, G.F. (1985). “Inhibition of RNA synthesis and interleukin 2 production in lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzoquinone.” Toxicol. Lett. 29:161-168.
64. Ruiz, M.A., Vassallo, J., and Desouza, C.A. (1991). “Morphologic study of the bone marrow of neutropenic patients exposed to benzene of the metallurgical industry of Cubatao, Sao Paulo, Brazil.” J. Occup. Med. 33:83.
65. Rushton, L. and Alderson, M.R. (1983). “Epidemiologic survey of oil distribution centers in Britain.” Br. J. Ind. Med. 40:330-339.
66. Sabourin, P.J., Sun, J.D., Birnbaum, L.S., Lucier, G., and Henderson, R.F. (1989). “Effect of repeated benzene inhalation exposures on subsequent metabolism of benzene.” Exper. Path. 37(1-4):155-157.
67. Sabourin, P.J., Sun, J.D., Macgregor, J.T., Wehr, C.M., Birnbaum, L.S., Lucier, G., and Henderson, R.F. (1990). “Effect of repeated benzene inhalation exposures on benzene metabolism, binding to hemoglobin, and induction of micronuclei. “ Toxicol. Appl. Pharmacol. 103(3):452-462.
68. Sandmeyer, E.E. (1981). “Aromatic hydrocarbons.” In: Patty's Industrial Hygiene and Toxicology (G.D. Clayton and F.E. Clayton, eds.). John Wiley and Sons, New York, NY. pp. 3253–3283.
69. Sato, A., Nakajima, T., Fujiwara, Y., and Murayama, N. (1975). “Kinetic studies on sex difference in susceptibility to chronic benzene intoxication—with special reference to body fat content. “ Br. J. Ind. Med. 32(4):321-328.
70. Siou, G., Conan, L., and El Haitem, M. (1981). “Evaluation of the clastogenic action of benzene by oral administration with 2 cytogenetic techniques in mouse and Chinese hamster.” Mutat. Res. 90:273-278.
71. Smolik, R., Grzybek-Hryncewicz, K., Lange, A., and Zatonski, W. (1973). “Serum complement level in workers exposed to benzene, toluene, and xylene.” Intl. Arch. Arbeitsmed. 31:243-247.
72. Snyder, C.A. (1987). “Benzene.” In: Ethel Browning's Toxicity and Metabolism of Industrial Solvents (R. Snyder, ed.). Elsevier Science Publishers, New York, NY. pp. 3–37.
73. Steineck, G., Plato, N., Gerhardsson, M., Norell, S.E., and Hogstedt, C. (1990). “Increased risk of urothelial cancer in Stockholm during 1985-87 after exposure to benzene and exhausts.” Intl. J. Cancer 45(6):1012-1017.
74. Steineck, G., Plato, N., Alfredson, L., and Norell, S.E. (1989). “Industry-related urothelial carcinogens, application of a job-exposure matrix on census data.” Am. J. Ind. Med. 16:209-224.
75. Superfund Amendments And Reauthorization Act (Sara) (1986). Public Law (PL) 99-499, codified together with CERCLA et 42 USC 9601, et seq.
76. Takeuchi, Y., Hisanaga, N., Ono, Y., Iwata, M., Oguri, S., and Tauchi, T. (1981). “An occupational health survey on dry cleaning workers.” Sangyo Igaku 23:407-418.
77. Texas Department Of Health (Tdh) (1993). Cancer Mortality Statistics: Texas 1980-1985, and 1986-1993. Bureau of Chronic Disease Prevention and Control, Cancer Registry Division, Austin, TX.
78. Thomas, T.L., Waxweiter, R.J., Moure, R.E., Itaya, S., and Fraumeni, J.F. (1982). “Mortality patterns among workers in three Texas oil refineries.” J. Occup. Med. 24:135-141.
79. Travis, L.B., Li, C.Y., Zhang, Z.N., Li, D.G., Yin, S.N., Chow, W.H., Li, G.L., Dosemeci, M., Blot, W., Fraumeni, J.F., JR., Hayes, R.B., and Linet, M.S. (1994). “Hematopoietic malignancies and related disorders among benzene- exposed workers in China.” Leukemia & Lymphoma. 14(1-2):91-102.
80. United States Environmental Protection Agency (Usepa) (1984) Health Effects Assessment for Benzene. NTIS PB86-134483. USEPA, Office of Emergency and Remedial Response, Washington, DC.
81. Winek, C.L. and Collom, W.D. (1971). “Benzene and toluene fatalities.” J. Occup. Med. 13:259-261.
82. Wong, O. (1987a). “An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results.” Br. J. Ind. Med. 44:365-381.
83. Wong, O. (1987b). “An industry-wide mortality study of chemical workers occupationally exposed to benzene. II. Dose-response analysis.” Br. J. Ind. Med. 44:382-395.
84. Zhu, H., Li, Y.B., and Trush, M.A. (1995). “Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats - implications for benzene-induced hematotoxicity.” J. Toxicol. Environ. Health 46(2):183-201.
85. Zoloth, S.R., Michaels, D.M., Villalbi, J.R., and Lacher, M. (1986). “Patterns of mortality among commercial pressmen. “ JNCI 76(6):1047-1051.